BASE Quote, Financials, Valuation and Earnings

Dynatrace has a net margin of -28.42% compared to Couchbase's net margin of 82.94%. Couchbase's return on equity of -58.28% beat Dynatrace's return on equity of 22.55%.

Couchbase has a consensus price target of $21.87, signalling upside risk potential of 53.45%. On the other hand Dynatrace has an analysts' consensus of $65.75 which suggests that it could grow by 32.49%. Given that Couchbase has higher upside potential than Dynatrace, analysts believe Couchbase is more attractive than Dynatrace.

Couchbase has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Dynatrace has a beta of 1.117, suggesting its more volatile than the S&P 500 by 11.688%.

Couchbase has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dynatrace offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Couchbase pays -- of its earnings as a dividend. Dynatrace pays out -- of its earnings as a dividend.

Couchbase quarterly revenues are $54.9M, which are smaller than Dynatrace quarterly revenues of $436.2M. Couchbase's net income of -$15.6M is lower than Dynatrace's net income of $361.8M. Notably, Couchbase's price-to-earnings ratio is -- while Dynatrace's PE ratio is 31.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Couchbase is 3.49x versus 9.17x for Dynatrace. Usually stocks with elevated PS ratios are considered overvalued.

GitLab has a net margin of -28.42% compared to Couchbase's net margin of 5.1%. Couchbase's return on equity of -58.28% beat GitLab's return on equity of -0.19%.

Couchbase has a consensus price target of $21.87, signalling upside risk potential of 53.45%. On the other hand GitLab has an analysts' consensus of $78.34 which suggests that it could grow by 53.13%. Given that Couchbase has higher upside potential than GitLab, analysts believe Couchbase is more attractive than GitLab.

Couchbase has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GitLab has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Couchbase has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GitLab offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Couchbase pays -- of its earnings as a dividend. GitLab pays out -- of its earnings as a dividend.

Couchbase quarterly revenues are $54.9M, which are smaller than GitLab quarterly revenues of $211.4M. Couchbase's net income of -$15.6M is lower than GitLab's net income of $10.8M. Notably, Couchbase's price-to-earnings ratio is -- while GitLab's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Couchbase is 3.49x versus 11.15x for GitLab. Usually stocks with elevated PS ratios are considered overvalued.

MongoDB has a net margin of -28.42% compared to Couchbase's net margin of 2.89%. Couchbase's return on equity of -58.28% beat MongoDB's return on equity of -8.08%.

Couchbase has a consensus price target of $21.87, signalling upside risk potential of 53.45%. On the other hand MongoDB has an analysts' consensus of $304.75 which suggests that it could grow by 60.34%. Given that MongoDB has higher upside potential than Couchbase, analysts believe MongoDB is more attractive than Couchbase.

Couchbase has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison MongoDB has a beta of 1.297, suggesting its more volatile than the S&P 500 by 29.701%.

Couchbase has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. MongoDB offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Couchbase pays -- of its earnings as a dividend. MongoDB pays out -- of its earnings as a dividend.

Couchbase quarterly revenues are $54.9M, which are smaller than MongoDB quarterly revenues of $548.4M. Couchbase's net income of -$15.6M is lower than MongoDB's net income of $15.8M. Notably, Couchbase's price-to-earnings ratio is -- while MongoDB's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Couchbase is 3.49x versus 7.23x for MongoDB. Usually stocks with elevated PS ratios are considered overvalued.

Zscaler has a net margin of -28.42% compared to Couchbase's net margin of -1.19%. Couchbase's return on equity of -58.28% beat Zscaler's return on equity of -1.22%.

Couchbase has a consensus price target of $21.87, signalling upside risk potential of 53.45%. On the other hand Zscaler has an analysts' consensus of $235.74 which suggests that it could grow by 19.18%. Given that Couchbase has higher upside potential than Zscaler, analysts believe Couchbase is more attractive than Zscaler.

Couchbase has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Zscaler has a beta of 0.882, suggesting its less volatile than the S&P 500 by 11.779%.

Couchbase has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zscaler offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Couchbase pays -- of its earnings as a dividend. Zscaler pays out -- of its earnings as a dividend.

Couchbase quarterly revenues are $54.9M, which are smaller than Zscaler quarterly revenues of $647.9M. Couchbase's net income of -$15.6M is lower than Zscaler's net income of -$7.7M. Notably, Couchbase's price-to-earnings ratio is -- while Zscaler's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Couchbase is 3.49x versus 12.49x for Zscaler. Usually stocks with elevated PS ratios are considered overvalued.